Australia Thyroid Cancer Diagnostics Market Size & Outlook

The thyroid cancer diagnostics market in Australia is expected to reach a projected revenue of US$ 113.7 million by 2027. A compound annual growth rate of 7.8% is expected of Australia thyroid cancer diagnostics market from 2020 to 2027.
Revenue, 2019 (US$M)
$62.5
Forecast, 2027 (US$M)
$113.7
CAGR, 2020 - 2027
7.8%
Report Coverage
Australia

Australia thyroid cancer diagnostics market highlights

  • The Australia thyroid cancer diagnostics market generated a revenue of USD 62.5 million in 2019 and is expected to reach USD 113.7 million by 2027.
  • The Australia market is expected to grow at a CAGR of 7.8% from 2020 to 2027.
  • In terms of segment, papillary carcinoma was the largest revenue generating type in 2019.
  • Follicular Carcinoma is the most lucrative type segment registering the fastest growth during the forecast period.


Thyroid cancer diagnostics market data book summary

Market revenue in 2019USD 62.5 million
Market revenue in 2027USD 113.7 million
Growth rate7.8% (CAGR from 2019 to 2027)
Largest segmentPapillary carcinoma
Fastest growing segmentFollicular Carcinoma
Historical data2016 - 2018
Base year2019
Forecast period2020 - 2027
Quantitative unitsRevenue in USD million
Market segmentationPapillary Carcinoma, Follicular Carcinoma
Key market players worldwideAbbott Laboratories, Roche, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, GE Aerospace, Koninklijke Philips NV, Toshiba Corporation, Agilent Technologies Inc, Illumina Inc


Other key industry trends

  • In terms of revenue, Australia accounted for 2.5% of the global thyroid cancer diagnostics market in 2019.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
  • In Asia Pacific, Japan thyroid cancer diagnostics market is projected to lead the regional market in terms of revenue in 2027.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 102.1 million by 2027.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Thyroid Cancer Diagnostics Market Companies

Name Profile # Employees HQ Website

Australia thyroid cancer diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thyroid cancer diagnostics market will help companies and investors design strategic landscapes.


Papillary carcinoma was the largest segment with a revenue share of 80.64% in 2019. Horizon Databook has segmented the Australia thyroid cancer diagnostics market based on papillary carcinoma, follicular carcinoma covering the revenue growth of each sub-segment from 2016 to 2027.


Reasons to subscribe to Australia thyroid cancer diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia thyroid cancer diagnostics market databook

  • Our clientele includes a mix of thyroid cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia thyroid cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Australia thyroid cancer diagnostics market from 2016 to 2027, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia thyroid cancer diagnostics market size, by type, 2016-2027 (US$M)

Australia Thyroid Cancer Diagnostics Market Outlook Share, 2019 & 2027 (US$M)

Australia thyroid cancer diagnostics market size, by type, 2016-2027 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more